Short: The Real Reason You're Not Losing Weight On A GLP-1

Most people who plateau on a GLP-1 medication assume the drug stopped working. The drug did not stop working. Something else happened first, and understanding that sequence changes everything about how you approach the medication.

GLP-1 agonists work by mimicking something called glucagon-like peptide-1, which is a hormone your gut naturally releases after eating to signal fullness to your brain. The medication keeps that signal elevated far longer than food ever would, which means your appetite drops dramatically and stays down. For most people, this is the first time in years, maybe decades, that food simply does not feel urgent. So they eat very little. And initially, the scale moves fast.

That fast early movement is where the confusion starts.

When you cut calories sharply, your body burns through its glycogen stores, which is the form of carbohydrate your liver and muscles hold as quick-access fuel. Each gram of glycogen is stored alongside three to four grams of water. So when you burn through those stores, you shed water too, and you can drop several pounds in the first week or two that have nothing to do with fat. It feels like the drug is working powerfully. And it is, but not entirely in the way people think.

Now here is where the plateau actually comes from.

When total food intake drops that low, protein intake almost always drops with it, because protein comes from food and there is simply less food coming in. And when the body is not getting enough protein, it faces a problem. It still needs amino acids to run basic functions, things like enzyme production, immune response, tissue repair. It has to get those amino acids from somewhere. So it pulls them from your own muscle tissue.

This process is called catabolism, which is the breakdown of body tissue for fuel or raw materials. The body is not being irrational. From a survival standpoint, muscle is expensive to maintain and optional if you are not using it, so it becomes a resource to draw from when external supply runs low.

The downstream effect of losing muscle is the part that creates the plateau.

Muscle tissue is metabolically active, meaning it burns calories just to exist. The more muscle you carry, the higher your resting metabolic rate, which is the number of calories your body burns doing nothing at all. When muscle breaks down, that rate drops. So the same calorie intake that was generating a deficit in week three is no longer generating much of a deficit in week ten, because the engine has gotten smaller. The deficit shrank not because you changed anything, but because your body changed underneath you.

That is the plateau. Not a drug failure. A composition problem.

The fix has two parts and neither one is complicated, though both require consistency.

The first is protein. The target that appears consistently in body composition research is roughly one gram per pound of goal body weight per day. If your goal weight is 170 pounds, you are targeting 170 grams of protein daily. This is not a flexible suggestion. On a GLP-1, when appetite suppression is making every meal feel optional, protein has to be treated like a prescription. You take it whether you feel like it or not.

The reason this number matters is that adequate protein gives your body a steady external supply of amino acids, which removes the pressure to cannibalize muscle tissue. The body only eats its own muscle when it has to. Give it what it needs from outside and it stops.

The second part is resistance training. Lifting weights two to three times per week sends a signal to the body that the muscle you are carrying is being used and therefore needs to be maintained. Without that signal, muscle loss is the path of least resistance. With it, the body has a reason to preserve what is there, and in some cases build more even while losing fat.

The case series from Tinsley and Nadolsky published in 2025 shows what happens when people on GLP-1 medications actually apply both of these. Patients using semaglutide or tirzepatide who trained three to five times per week and prioritized protein lost an average of 33 percent of their body weight, and only 6.9 percent of that loss came from lean soft tissue. One patient lost 26.8 percent of their body weight and actually gained 2.5 percent muscle mass in the process. Same drug class, radically different body composition outcomes.

The variable was not the medication. It was what the patients did while the medication was suppressing their appetite.

This is worth sitting with for a moment. Two people can be on identical doses of the same GLP-1 medication, lose the same total amount of weight on the scale, and end up in completely different metabolic positions at the end. One person preserved muscle, kept their metabolic rate high, and set themselves up to maintain the loss. The other lost significant lean tissue, lowered their resting calorie burn, and is far more likely to plateau and regain. The scale showed the same number. The bodies are not the same.

GLP-1 medications are a powerful appetite suppression tool. What they are not is a complete strategy on their own. The appetite suppression opens a window where eating less becomes genuinely manageable for the first time, and that is real and worth using. But the window is only useful if you fill it with the right inputs.

The drug changes the conditions. You still have to control the outcome.

---

References

1. Tinsley GM, Nadolsky S. Preservation of lean soft tissue during weight loss induced by GLP-1 and GLP-1/GIP receptor agonists: A case series. SAGE Open Medical Case Reports. 2025. Finding: Patients on semaglutide/tirzepatide who trained 3-5x/week and prioritized protein lost 33% body weight with only 6.9% muscle loss; one gained 2.5% muscle while losing 26.8% body weight. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness